Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Contributions to Nephrology
|
December 18, 2004
Intensive chemotherapy in patients with lymphoma. Management of the risk of hyperuricemia
Corrado Tarella, Davide Bono, Manuela Zanni, et al.
Cancers
|
April 3, 2021
Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer's Achilles' Heel
Daniele Caracciolo, Caterina Riillo, Maria Teresa Di Martino, et al.
Reviews on Recent Clinical Trials
|
January 27, 2026
Endoscopic Progression of Gastric DLBCL in an HIV-Positive Patient: A Case Report and Literature Review
Giuseppe Quintieri, Alessandro Corea, Carmen Colaci, et al.
Current Cancer Drug Targets
|
April 1, 2017
Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment
Cirino Botta, Maria Cuce, Daniele Caracciolo, et al.
International Journal of Cancer
|
May 9, 2020
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment
Daniele Caracciolo, Caterina Riillo, Mariamena Arbitrio, et al.
Molecular Therapy. Nucleic Acids
|
March 9, 2020
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats
Maria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, et al.
Current Drug Targets
|
July 10, 2013
From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario
Marco Rossi, Nicola Amodio, M T Di Martino, et al.
Expert Opinion on Therapeutic Targets
|
March 10, 2016
Mir-221/222 are promising targets for innovative anticancer therapy
Maria Teresa Di Martino, Marco Rossi, Daniele Caracciolo, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
December 13, 2021
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients
Francesca Scionti, Maria Teresa Di Martino, Daniele Caracciolo, et al.
Journal of Hematology & Oncology
|
May 10, 2018
MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches
Nicola Amodio, Lavinia Raimondi, Giada Juli, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Contributions to Nephrology
|
December 18, 2004
Intensive chemotherapy in patients with lymphoma. Management of the risk of hyperuricemia
Corrado Tarella, Davide Bono, Manuela Zanni, et al.
Cancers
|
April 3, 2021
Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer's Achilles' Heel
Daniele Caracciolo, Caterina Riillo, Maria Teresa Di Martino, et al.
Reviews on Recent Clinical Trials
|
January 27, 2026
Endoscopic Progression of Gastric DLBCL in an HIV-Positive Patient: A Case Report and Literature Review
Giuseppe Quintieri, Alessandro Corea, Carmen Colaci, et al.
Current Cancer Drug Targets
|
April 1, 2017
Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment
Cirino Botta, Maria Cuce, Daniele Caracciolo, et al.
International Journal of Cancer
|
May 9, 2020
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment
Daniele Caracciolo, Caterina Riillo, Mariamena Arbitrio, et al.
Molecular Therapy. Nucleic Acids
|
March 9, 2020
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats
Maria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, et al.
Current Drug Targets
|
July 10, 2013
From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario
Marco Rossi, Nicola Amodio, M T Di Martino, et al.
Expert Opinion on Therapeutic Targets
|
March 10, 2016
Mir-221/222 are promising targets for innovative anticancer therapy
Maria Teresa Di Martino, Marco Rossi, Daniele Caracciolo, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
December 13, 2021
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients
Francesca Scionti, Maria Teresa Di Martino, Daniele Caracciolo, et al.
Journal of Hematology & Oncology
|
May 10, 2018
MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches
Nicola Amodio, Lavinia Raimondi, Giada Juli, et al.
Page
of 8